Pharmaceutical compositions and dosage forms are disclosed that comprise a racemic or optically pure sibutramine metabolite and a phosphodiesterase inhibitor.

 
Web www.patentalert.com

< Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque

< Oil from Momordica charantia L., its method of preparation and uses

> Isolated stromal cells and methods of using the same

> Therapeutic agents
~ 00226